Petmed Express's biggest risks in the FY2025 10-K
- PetMeds faces severe regulatory, operational, and financial risks highlighted by material internal control weaknesses, customer concentration in eight states, and intense competition from veterinarians.
The risks most specific to Petmed Express
- Regulatory Risks
Any failure to comply with various state or federal regulations covering our pet health business, including the dispensing of prescription pet medications may subject us to reprimands, sanctions, probations, fines, suspensions, or the loss of one or more of our pharmacy licenses
Failure to comply with state and federal regulations on dispensing prescription pet medications could result in fines, sanctions, or the loss of our pharmacy licenses.
- Business Risks
Resistance from veterinarians to authorize prescriptions, or attempts or efforts by veterinarians to discourage pet owners from purchasing from us could cause our sales to decrease and could materially adversely affect our financial condition and results of operations
Veterinarian resistance to authorizing prescriptions or attempts to discourage pet owners from purchasing from us could cause our sales to decrease.
- Business Risks
Significant portions of our sales are made to residents of eight states. If we should lose our pharmacy license in one or more of these states, our financial condition and results of operations would be materially adversely affected
Approximately 50% of our sales are concentrated in eight states, meaning the loss of a pharmacy license in any of them would harm our business.
- Business Risks
Since most of our operations are housed in a single location, we are more susceptible to a business interruption in the event of damage to, or disruptions in, our facility, particularly with respect to extreme weather events
Most of our operations and primary distribution centers are housed in single locations in South Florida and New York, making us vulnerable to business interruptions and extreme weather.
- Business Risks
Our migration of data and systems to a new information technology platform may disrupt our operations
Migrating and upgrading our legacy websites and back-end systems to new modular and SaaS platforms may disrupt our operations.
- Financial Risks
We may face litigation and other risks as a result of the restatements described in this Comprehensive Form 10-K and the Amended Reports and material weaknesses in our internal control over financial reporting
Material weaknesses in our internal control over financial reporting and recent restatements could expose us to SEC regulatory action or potential litigation.
- Industry Risks
We face significant competition from veterinarians and online and traditional retailers, as well as challenges from strategic alliances amongst our competitors, and may not be able to compete profitably with them
We face significant competition from veterinarians who hold a natural advantage by selling medications directly to pet owners during office visits.
- Industry Risks
Our ability to pay regular dividends to our shareholders and the amounts of any such dividends are subject to the discretion of the Board and may be limited by our financial condition, or limitations under Florida law
We suspended our quarterly dividend indefinitely in February 2024 to reserve cash for strategic transactions and investments.
All 32 risk factors
Headings as the filing states them, in filing order.
Regulatory Risks
- 01Any failure to comply with various state or federal regulations covering our pet health business, including the dispensing of prescription pet medications may subject us to reprimands, sanctions, probations, fines, suspensions, or the loss of one or more of our pharmacy licenses
Business Risks
- 02Our failure to properly manage our inventory may result in excessive inventory carrying costs, or inadequate supply of products, which could materially adversely affect our financial condition and results of operations
- 03Resistance from veterinarians to authorize prescriptions, or attempts or efforts by veterinarians to discourage pet owners from purchasing from us could cause our sales to decrease and could materially adversely affect our financial condition and results of operations
- 04Significant portions of our sales are made to residents of eight states. If we should lose our pharmacy license in one or more of these states, our financial condition and results of operations would be materially adversely affected
- 05We have direct buying relationships with all the major pet medication manufacturers and each contractual relationship depends on our compliance with each respective manufacturer’s minimum advertised pricing policies (MAPP)
- 06The loss of any of our key suppliers would negatively impact our business
- 07Shipping is a critical part of our business and any changes in, or disruptions to, our shipping arrangements could adversely affect our business, financial condition, and results of operations
- 08The quality of our customer service and support is important to our customers, and if we fail to provide adequate levels of customer service and support, we could lose customers, which would harm our business
- 09The content of our websites could expose us to various kinds of liability, which, if prosecuted successfully, could negatively impact our business
- 10We may not be able to protect our intellectual property rights, and/or we may be found to infringe on the proprietary rights of others
- 11If we are unable to protect our Internet addresses or to prevent others from using Internet addresses that are confusingly similar, our business may be adversely impacted
- 12Since most of our operations are housed in a single location, we are more susceptible to a business interruption in the event of damage to, or disruptions in, our facility, particularly with respect to extreme weather events
- 13A failure or misuse of our information systems and customer-facing technology systems, including our online payment methods, could adversely affect our results of operations, expose us to third-party claims, or increase our exposure to fraud and other risks
- 14Our failure or the failure of third-party service providers to protect our websites, networks, and systems against cybersecurity incidents, or otherwise to protect our confidential information, could damage our reputation and brands and substantially harm our business, financial condition, and results of operations
- 15Our migration of data and systems to a new information technology platform may disrupt our operations
- 16interruptions may increase. Further, our transition could involve significant time and expense and could negatively impact our ability to deliver our products and services, which could harm our financial condition and results of operations
- 17We face the risk of litigation resulting from unauthorized text messages sent in violation of the Telephone Consumer Protection Act
- 18Our operating results are difficult to predict and may fluctuate, and a portion of our sales are seasonal
- 19Uncertainties in economic conditions and their impact on consumer spending patterns could adversely impact our business, financial condition, and results of operations
- 20increased acceptance and utilization of telemedicine services, but it is uncertain whether such increase in demand will continue
- 21Evolving foreign trade policy by the United States or other countries or the imposition of tariffs on imported goods may affect our business
Financial Risks
- 22We are subject to payment-related risks that could increase our operating costs, expose us to fraud or theft, subject us to potential liability and potentially disrupt our business
- 23We may face litigation and other risks as a result of the restatements described in this Comprehensive Form 10-K and the Amended Reports and material weaknesses in our internal control over financial reporting
Risks Relating to Taxes
- 24Taxing authorities may successfully assert that we should have collected, or in the future should collect, sales and use, value added, or similar taxes, and any such assessments could adversely affect our business, financial condition, and results of operations
- 25requiring us to register, calculate, collect, and remit taxes on sales in their jurisdictions. Additionally, states and some local tax jurisdictions have differing rules and regulations governing sales and use taxes, which are subject to varying interpretations that may change over time
- 26Changes in tax laws or regulations in the various tax jurisdictions we are subject to could increase our cost of doing business
Industry Risks
- 27We face significant competition from veterinarians and online and traditional retailers, as well as challenges from strategic alliances amongst our competitors, and may not be able to compete profitably with them
- 28Product recalls and concerns regarding the safety and quality of the pet products we sell could affect our business
- 29Pandemics or other health crises, such as the possible resurgence of the COVID-19 pandemic, may adversely affect our results of operations
- 30Our stock price fluctuates from time to time and may fall below expectations of securities analysts and investors, and could subject us to litigation, which may result in you suffering a loss on your investment
- 31We may issue additional shares of preferred stock that could defer a change of control or dilute the interests of our common shareholders. Our charter documents could defer a takeover effort which could inhibit your ability to receive an acquisition premium for your shares
- 32Our ability to pay regular dividends to our shareholders and the amounts of any such dividends are subject to the discretion of the Board and may be limited by our financial condition, or limitations under Florida law
Other Petmed Express 10-Ks
- FY2026 10-K risk factors32 risks4 new4 dropped3 reworded
The company now flags substantial doubt about continuing as a going concern due to declining cash, sales, losses, and negative operating cash flow.
Filed Jun 02, 2026
About this page
The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.